Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiformeCorey Smith, Rajiv Khanna, Katie E. Lineburg et al.|Journal of Clinical Investigation|2020Cited by 64
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinomaCorey Smith, Rajiv Khanna, Margaret McGrath et al.|npj Precision Oncology|2021Cited by 31
T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical responseCorey Smith, Rajiv Khanna, Dillon Corvino et al.|Journal of Clinical Investigation|2019Cited by 24
'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignanciesDebottam Sinha, Rajiv Khanna, Pauline Crooks et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 21
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Corey Smith, Katie E. Lineburg et al.|PLoS Pathogens|2022Cited by 21